A method of diagnosing cardiac toxicity in patients with non-Hodgkin lymphoma DURING CHEMOTHERAPY

摘要

method of diagnosing u043au0430u0440u0434u0438u043eu0442u043eu043au0441u0438u0447u043du043eu0441u0442u0438 patients u043du0435u0445u043eu0434u0436u043au0438u043du0441u043au0438u043cu0438 u043bu0438u043cu0444u043eu043cu0430u043cu0438 during chemotherapy by u0438u0441u0441u043bu0435u0434u043eu0432u0430u043du0438u00a0 cardiovascular system: echo kg, a u043du0438u00a0 daily ekg - u043cu043eu043du0438u0442u043eu0440u0438u0440u043eu0432u0430u043du0438u00a0 before and after chemotherapy u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 u043fu0440u043eu0432u0435u0434u0435u043du0438u00a0 so that further u043fu0440u043eu0432u043eu0434u00a0u0442 definition u0445u0435u043cu0438u043bu044eu043cu0438u043du0435u0441u0446u0435u043du0446u0438u0438 count, ant u0438u043fu0435u0440u0435u043au0438u0441u043du043eu0439 activity of plasma.u043cu0430u043bu043eu043du043eu0432u043eu0433u043e u0434u0438u0430u043bu044cu0434u0435u0433u0438u0434u0430 originally, and in the process of chemotherapy, after which u043fu0440u043eu0432u043eu0434u00a0u0442 assessment u0432u0435u0440u043eu00a0u0442u043du043eu0441u0442u0438 u0440u0430u0437u0432u0438u0442u0438u00a0 patients depending on the degree of u043au0430u0440u0434u0438u043eu0442u043eu043au0441u0438u0447u043du043eu0441u0442u0438 t the degree of u043fu043eu0432u044bu0448u0435u043du0438u00a0 u0443u0440u043eu0432u043du00a0 u0445u0435u043cu0438u043bu044eu043cu0438u043du0435u0441u0446u0435u043du0446u0438u0438, u043fu0435u0440u0435u043au0438u0441u043du043eu0433u043e u043eu043au0438u0441u043bu0435u043du0438u00a0 lipid and u0441u043du0438u0436u0435u043du0438u00a0 u0430u043du0442u0438u043eu043au0441u0438u0434u0430u043du0442u043du043eu0439 protection.